P16 Immunoreactivity Is an Independent Predictor of Tumor Progression in Minimally Invasive Urothelial Bladder Carcinoma

International Histological Classification of Tumours

RO Weller · Journal of Clinical Pathology · 1981 · 2K citations · Full text

Veterinary Medicine, Oncology, Pathology +12

p53, p21, pRB, and p16 Expression Predict Clinical Outcome in Cystectomy With Bladder Cancer

Shahrokh F. Shariat, Hideo Tokunaga, Jain-Hua Zhou et al. · Journal of Clinical Oncology · 2004 · 330 citations · Full text

Medicine, Oncology, Pathology +17

<i>p16 (CDKN2)</i> is a major deletion target at 9p21 in bladder cancer

Magali Williamson, Patricia A. Elder, Margaret E. Shaw et al. · Human Molecular Genetics · 1995 · 175 citations

Medicine, Genetics, Oncology +14

Substaging of T1 bladder carcinoma based on the depth of invasion as measured by micrometer

Liang Cheng, Amy L. Weaver, Roxann M. Neumann et al. · Cancer · 1999 · 135 citations · Full text

Medicine, Oncology, Surgery +17

Deletions of the INK4A Gene in Superficial Bladder Tumors

Irene Orlow, Hélène LaRue, Iman Osman et al. · American Journal Of Pathology · 1999 · 133 citations · Full text

Medicine, Genetics, Molecular Genetics +9